S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RTW Investments/Q1 2022

RTW Investments

Period: Q1 2022 Β· Filed: 2022-05-16
View on SEC EDGAR β†—
AUM
$4.83B
Total portfolio value
Positions
106
Reported securities
Top Holding
ALNY
5.7% $274.9M
QoQ Changes
+2 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2022-05-16) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
ALNYALNYLAM PHARMACEUTICALS INC$274.9M5.69%$163.29$312.78+91.5%
5.7%
RCKTROCKET PHARMACEUTICALS INC$250.6M5.19%$15.86$3.84-75.8%
5.2%
TMOTHERMO FISHER SCIENTIFIC INC$220.3M4.56%$583.28$523.44-10.3%
4.6%
PTCTPTC THERAPEUTICS INC$194.8M4.03%$37.31$83.31+123.3%
4.0%
ILMNILLUMINA INC$178.0M3.68%$339.88$188.68-44.5%
3.7%
MASIMASIMO CORP$164.1M3.40%$145.54β€”
3.4%
ESTAESTABLISHMENT LABS HLDGS INC$156.3M3.23%$67.39$89.25+32.4%
3.2%
VCELVERICEL CORP$153.6M3.18%$38.22$46.98+22.9%
3.2%
PENPENUMBRA INC$147.9M3.06%$222.13$318.57+43.4%
3.1%
MRTXMIRATI THERAPEUTICS INC$128.4M2.66%β€”β€”
2.7%
GMEDGLOBUS MED INC$124.1M2.57%$73.78$80.12+8.6%
2.6%
TNDMTANDEM DIABETES CARE INC$116.9M2.42%$116.29$15.32-86.8%
2.4%
PTGXPROTAGONIST THERAPEUTICS INC$113.5M2.35%$23.68$131.62+455.8%
2.4%
CCCCC4 THERAPEUTICS INC$110.0M2.28%$24.26$4.30-82.3%
2.3%
AXNXAXONICS INC$109.2M2.26%β€”β€”
2.3%
ARGXARGENX SE$106.3M2.20%$315.31$939.68+198.0%
2.2%
CUTRQCUTERA INC$105.3M2.18%β€”β€”
2.2%
CLDXCELLDEX THERAPEUTICS INC NEW$105.0M2.17%$34.06$38.37+12.7%
2.2%
RXDXPROMETHEUS BIOSCIENCES INC$104.1M2.16%β€”β€”
2.2%
RAREULTRAGENYX PHARMACEUTICAL IN$99.7M2.06%$72.62$33.47-53.9%
2.1%
CYTKCYTOKINETICS INC$94.3M1.95%$36.81$86.49+135.0%
1.9%
RNAMAVIDITY BIOSCIENCES INC$88.6M1.83%β€”β€”
1.8%
FULCFULCRUM THERAPEUTICS INC$85.4M1.77%$23.65$3.84-83.8%
1.8%
PMVPPMV PHARMACEUTICALS INC$80.6M1.67%$20.82$1.22-94.1%
1.7%
NTRANATERA INC$78.0M1.61%$40.68$279.32+586.6%
1.6%
STOKSTOKE THERAPEUTICS INC$76.7M1.59%$21.05$32.70+55.3%
1.6%
RLMDRELMADA THERAPEUTICS INC$68.6M1.42%$26.99$6.28-76.7%
1.4%
AXSMAXSOME THERAPEUTICS INC$67.0M1.39%$41.39$244.31+490.3%
1.4%
RGNXREGENXBIO INC$61.3M1.27%$33.19$13.28-60.0%
1.3%
ACETADICET BIO INC$59.7M1.24%$319.52$9.00-97.2%
1.2%

Quarter-on-Quarter Activity

Q1 2022 vs. Q4 2021

New Positions (2)

TickerIssuerNotional
CINCCINCOR PHARMA INC$24.4M
TSVT2SEVENTY BIO INC$21.0M

Exited Positions (8)

TickerIssuerNotional
SPYSPDR S&P 500 ETF TR$422.6M
ISEEIVERIC BIO INC$112.4M
IDYAIDEAYA BIOSCIENCES INC$59.6M
SRPTSAREPTA THERAPEUTICS INC$52.4M
BLUBELLUS HEALTH INC NEW$48.0M
ARWRARROWHEAD PHARMACEUTICALS IN$23.0M
CERECEREVEL THERAPEUTICS HLDNG I$21.6M
NEONEOGENOMICS INC$10.6M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
PTGXPROTAGONIST THERAPEUTICS INC$24.6M+84.4%+455.8%
QTRXQUANTERIX CORP$7.3M+81.9%
CCCCC4 THERAPEUTICS INC$29.6M+81.6%-82.3%
JNCEJOUNCE THERAPEUTICS INC$7.9M+63.5%
IMUXIMMUNIC INC$14.2M+57.7%
IMCRIMMUNOCORE HLDGS PLC$12.9M+49.3%
BCYCBICYCLE THERAPEUTICS PLC$3.1M+46.8%
MASIMASIMO CORP$-84.7M+32.7%

Trimmed (8)

TickerIssuerNotionalShares Ξ”
APLSAPELLIS PHARMACEUTICALS INC$-91.5M-97.4%
ADVMADVERUM BIOTECHNOLOGIES INC$-13.0M-97.0%
JNJJOHNSON & JOHNSON$-18.2M-85.5%
ITOSITEOS THERAPEUTICS INC$-93.8M-79.2%
AGENAGENUS INC$-10.1M-39.0%
NSTGQNANOSTRING TECHNOLOGIES INC$-11.5M-33.1%
LUNGPULMONX CORP$-17.5M-31.5%
MXCTMAXCYTE INC$-1.4M-27.4%
← Back to Hedge Funds